圣·约翰草提取物对老年2型糖尿病患者并存抑郁症的疗效观察

目的 探讨抗抑郁植物药圣·约翰草提取物对并存抑郁症的老年2型糖尿病患者的临床疗效及对血糖的影响. 方法 将并存抑郁症的老年2型糖尿病患者118例随机分为5组,圣·约翰草提取物组(26例)、劳拉西泮组(22例)、心理组(24例)、物理组(24例)和对照组(22例),均治疗12周.以汉密尔顿抑郁量表(HAMD)减分率评定疗效,采用糖化血红蛋白(HbAlc)水平监测血糖控制情况. 结果 (1)治疗12周后,4个治疗组HAMD减分率分别为80.8%、63.6%、62.5%、58.3%,与对照组(18.2%)比较,差异有统计学意义(P<0.01),圣·约翰草提取物组疗效优于其他3组(P<0.05);(2)治疗12周后,圣·约翰草提取物组HbAIt(6.5±0.6)%,比治疗前明显下降(P<0.01),且优于其他3组[分别为(7.5±0.8)%、(7.4±0.8)%和(7.4±1.0)%]. 结论 圣·约翰草提取物能显著改善老年2型糖尿病患者伴发的抑郁症状,且有利于患者的血糖控制.

Therapeutic effects of St. John's Wort extract on depressive disorder in elderly patients with diabetes

Objective To explore the clinical therapeutic effects of St. John's Wort exact (SWE)on depressive disorder and blood glucose in elderly type 2 diabetic patients Methods 118 patients with type 2 diabetes and depressive disorder were randomly assigned to SWE group (26 cases),lorazepam group (22 cases ), psychotherapy group (24 cases), physicotherapy group (24 cases) and control group (routine therapy,22 cases) for 12 weeks' treatment. The clinical effects were evaluated with the percentage reduction in HAMD score after the treatment, HbAlc levels were obtained to monitor glycemic control. Results (1) The percentage reduction in HAMD score in SWE group was the highest (80. 8%), and it was lower in lorazepam group ( 63. 6%), psychotherapy group (62. 5%) and physicotherapy group(58. 3%). The percent decrease in H AMD score was higher in four groups than in control group ( 18. 2%) and the difference was significant (P < 0. 01). The therapeutic effect of SWE was better than the others(P0. 05). (2) The level of HbAlc in SWE group (6.5±0. 6)% was significantly lower than the others [( 7. 5 ± 0. 8) %, (7.4 ± 0. 8) %, (7. 4 ±1.0) % (P < 0. 01 )]. Conclusions St. John' s Wort exact (SWE) can efficiently improve the depressive disorder in elderly type 2 diabetic patients, and it is good for controlling blood glucose of the patients.